GlassScriptPhysician profile
Chris Roberts
NPI 1225674419
$1,478.48
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $395 · 2022: $274 · 2023: $705 · 2024: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.15 |
| Education | $146.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $596.59 | 2021-2023 | Lybalvi, Aristada, Aristada Initio |
| Abbvie INC. | $339.25 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $274.64 | 2021-2023 | Invega Sustenna |
| Supernus Pharmaceuticals, INC. | $101.86 | 2023-2024 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $67.03 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $33.19 | 2022-2023 | Austedo |
| Otsuka America Pharmaceutical, INC. | $27.65 | 2021 | |
| Indivior INC. | $24.06 | 2024 | Sublocade |
| Hikma Pharmaceuticals USA | $14.21 | 2023 | Kloxxado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.